RLYB (Rallybio) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RLYB Rallybio Corp RLYB
28 GF Score
Price $16.69
! 5 Warning Signs
View Full Analysis

What is Rallybio Net Loan?

Net Loan only applies to banks and insurance companies.

RLYB
28GF Score
Rallybio Corp RLYB
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rallybio Business Description

Other Exchanges 33M0:Germany
Address 234 Church Street, Suite 1020, New Haven, CT, USA, 06510
Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.
28GF Score

Get the complete analysis for RLYB

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.69
Price